Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Evaluation of novel orthotopic nude mouse models for human small-cell lung cancerTakeshi Isobe, Amir Onn, Daniel Morgensztern, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2007
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transductionHovav Nechushtan, Dien Pham, Yu Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2022
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung CancerJessika Contreras, Amar Srivastava, Pamela Samson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2016
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLCDaniel Morgensztern, Lingling Du, Saiama N Waqar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2025
JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade TherapiesDi Kang, Yanping Wang, Yiwei Lin, et al.
The Annals of Thoracic Surgery|April 24, 2017
Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung CancerUsman Ahmad, Traves D Crabtree, Aalok P Patel, et al.
Frontiers in Oncology|February 12, 2021
<i>nab</i>-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled AnalysisCorey J Langer, Ajeet Gajra, Cesare Gridelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLCChristine L Hann, Timothy F Burns, Afshin Dowlati, et al.
Clinical Lung Cancer|May 26, 2022
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung CancerSalma K Jabbour, Byoung Chul Cho, Emilio Bria, et al.
Frontiers in Oncology|April 14, 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung CancerBrendan Knapp, Laura Mezquita, Siddhartha Devarakonda, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Evaluation of novel orthotopic nude mouse models for human small-cell lung cancerTakeshi Isobe, Amir Onn, Daniel Morgensztern, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2007
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transductionHovav Nechushtan, Dien Pham, Yu Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2022
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung CancerJessika Contreras, Amar Srivastava, Pamela Samson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2016
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLCDaniel Morgensztern, Lingling Du, Saiama N Waqar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2025
JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade TherapiesDi Kang, Yanping Wang, Yiwei Lin, et al.
The Annals of Thoracic Surgery|April 24, 2017
Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung CancerUsman Ahmad, Traves D Crabtree, Aalok P Patel, et al.
Frontiers in Oncology|February 12, 2021
<i>nab</i>-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled AnalysisCorey J Langer, Ajeet Gajra, Cesare Gridelli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLCChristine L Hann, Timothy F Burns, Afshin Dowlati, et al.
Clinical Lung Cancer|May 26, 2022
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung CancerSalma K Jabbour, Byoung Chul Cho, Emilio Bria, et al.
Frontiers in Oncology|April 14, 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung CancerBrendan Knapp, Laura Mezquita, Siddhartha Devarakonda, et al.
Pageof 19